Literature DB >> 21514661

The optimization of polymalic acid peptide copolymers for endosomolytic drug delivery.

Hui Ding1, Jose Portilla-Arias, Rameshwar Patil, Keith L Black, Julia Y Ljubimova, Eggehard Holler.   

Abstract

Membranolytic macromolecules are promising vehicles for cytoplasmic drug delivery, but their efficiency and safety remains primary concerns. To address those concerns, membranolytic properties of various poly(β-L-malic acid) (PMLA) copolymers were extensively investigated as a function of concentration and pH. PMLA, a naturally occurring biodegradable polymer, acquires membranolytic activities after substitution of pendent carboxylates with hydrophobic amino acid derivatives. Ruled by hydrophobization and charge neutralization, membranolysis of PMLA copolymers increased as a function of polymer molecular weight and demonstrated a maximum with 50% substitution of carboxylates. Charge neutralization was achieved either conditionally by pH-dependent protonation or permanently by masking carboxylates. Membranolysis of PMLA copolymers containing tripeptides of leucine, tryptophan and phenylalanine were pH-dependent in contrast to pH-independent copolymers of Leucine ethyl ester and Leu-Leu-Leu-NH(2) with permanent charge neutralization. PMLA and tripeptides seemed a unique combination for pH-dependent membranolysis. In contrast to nontoxic pH-dependent PMLA copolymers, pH-independent copolymers were found toxic at high concentration, which is ascribed to their nonspecific disruption of plasma membrane at physiological pH. pH-Dependent copolymers were membranolytically active only at acidic pH typical of maturating endosomes, and are thus devoid of cytotoxicity. The PMLA tripeptide copolymers are useful for safe and efficient cytoplasmic delivery routed through endosome.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514661      PMCID: PMC4110056          DOI: 10.1016/j.biomaterials.2011.03.073

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  37 in total

Review 1.  How proteins adapt to a membrane-water interface.

Authors:  J A Killian; G von Heijne
Journal:  Trends Biochem Sci       Date:  2000-09       Impact factor: 13.807

2.  Beta-poly(L-malate) production by non-growing microplasmodia of Physarum polycephalum. Effects of metabolic intermediates and inhibitors.

Authors:  B S Lee; E Holler
Journal:  FEMS Microbiol Lett       Date:  2000-12-01       Impact factor: 2.742

3.  Targeted lysosome disruptive elements for improvement of parenchymal liver cell-specific gene delivery.

Authors:  Sabine M W Van Rossenberg; Karen M Sliedregt-Bol; Nico J Meeuwenoord; Theo J C Van Berkel; Jacques H Van Boom; Gijs A Van Der Marel; Erik A L Biessen
Journal:  J Biol Chem       Date:  2002-09-16       Impact factor: 5.157

4.  Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting.

Authors:  Shyh-Dar Li; Leaf Huang
Journal:  J Control Release       Date:  2010-03-23       Impact factor: 9.776

Review 5.  Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents.

Authors:  Rudolph L Juliano; Rowshon Alam; Vidula Dixit; Hyun Min Kang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2009 May-Jun

6.  Assessing side-chain perturbations of the protein backbone: a knowledge-based classification of residue Ramachandran space.

Authors:  David B Dahl; Zach Bohannan; Qianxing Mo; Marina Vannucci; Jerry Tsai
Journal:  J Mol Biol       Date:  2008-02-29       Impact factor: 5.469

7.  Calculating number and surface area of liposomes in any suspension.

Authors:  C Pidgeon; C A Hunt
Journal:  J Pharm Sci       Date:  1981-02       Impact factor: 3.534

8.  Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis.

Authors:  Manabu Fujita; Natalya M Khazenzon; Alexander V Ljubimov; Bong-Seop Lee; Ismo Virtanen; Eggehard Holler; Keith L Black; Julia Y Ljubimova
Journal:  Angiogenesis       Date:  2006-11-16       Impact factor: 9.596

9.  Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions.

Authors:  David J Schibli; Raquel F Epand; Hans J Vogel; Richard M Epand
Journal:  Biochem Cell Biol       Date:  2002       Impact factor: 3.626

Review 10.  Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery.

Authors:  Julia Y Ljubimova; Manabu Fujita; Alexander V Ljubimov; Vladimir P Torchilin; Keith L Black; Eggehard Holler
Journal:  Nanomedicine (Lond)       Date:  2008-04       Impact factor: 5.307

View more
  17 in total

1.  Polymalic acid chlorotoxin nanoconjugate for near-infrared fluorescence guided resection of glioblastoma multiforme.

Authors:  Rameshwar Patil; Anna Galstyan; Tao Sun; Ekaterina S Shatalova; Pramod Butte; Adam N Mamelak; Christine Carico; David S Kittle; Zachary B Grodzinski; Antonella Chiechi; Hui Ding; Keith L Black; Julia Y Ljubimova; Eggehard Holler
Journal:  Biomaterials       Date:  2019-03-23       Impact factor: 12.479

2.  Polymalic Acid Tritryptophan Copolymer Interacts with Lipid Membrane Resulting in Membrane Solubilization.

Authors:  Hui Ding; Irving Fox; Rameshwar Patil; Anna Galstyan; Keith L Black; Julia Y Ljubimova; Eggehard Holler
Journal:  J Nanomater       Date:  2017-05-21       Impact factor: 2.986

Review 3.  Nanotechnology in corneal neovascularization therapy--a review.

Authors:  Lilian Gonzalez; Raymond J Loza; Kyu-Yeon Han; Suhair Sunoqrot; Christy Cunningham; Patryk Purta; James Drake; Sandeep Jain; Seungpyo Hong; Jin-Hong Chang
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-20       Impact factor: 2.671

4.  Intensification of β-poly(L: -malic acid) production by Aureobasidium pullulans ipe-1 in the late exponential growth phase.

Authors:  Weifeng Cao; Jianquan Luo; Juan Zhao; Changsheng Qiao; Luhui Ding; Benkun Qi; Yi Su; Yinhua Wan
Journal:  J Ind Microbiol Biotechnol       Date:  2012-03-07       Impact factor: 3.346

5.  Biocompatible nanopolymers: the next generation of breast cancer treatment?

Authors:  Julia Y Ljubimova; Eggehard Holler
Journal:  Nanomedicine (Lond)       Date:  2012-10       Impact factor: 5.307

Review 6.  Covalent nano delivery systems for selective imaging and treatment of brain tumors.

Authors:  Julia Y Ljubimova; Tao Sun; Leila Mashouf; Alexander V Ljubimov; Liron L Israel; Vladimir A Ljubimov; Vida Falahatian; Eggehard Holler
Journal:  Adv Drug Deliv Rev       Date:  2017-06-10       Impact factor: 15.470

7.  Distinct mechanisms of membrane permeation induced by two polymalic acid copolymers.

Authors:  Hui Ding; Jose Portilla-Arias; Rameshwar Patil; Keith L Black; Julia Y Ljubimova; Eggehard Holler
Journal:  Biomaterials       Date:  2012-10-09       Impact factor: 12.479

8.  Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer.

Authors:  Hui Ding; Gustavo Helguera; José A Rodríguez; Janet Markman; Rosendo Luria-Pérez; Pallavi Gangalum; Jose Portilla-Arias; Satoshi Inoue; Tracy R Daniels-Wells; Keith Black; Eggehard Holler; Manuel L Penichet; Julia Y Ljubimova
Journal:  J Control Release       Date:  2013-06-12       Impact factor: 9.776

9.  Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment.

Authors:  Jose Portilla-Arias; Rameshwar Patil; Hui Ding; Julia Y Ljubimova; Satoshi Inoue; Janet L Markman; Arthur Rekechenetskiy; Bindu Konda; Pallavi R Gangalum; Alexandra Chesnokova; Alexander V Ljubimov; Keith L Black; Eggehard Holler
Journal:  J Drug Target       Date:  2013-09-16       Impact factor: 5.121

Review 10.  Journey to the Center of the Cell: Current Nanocarrier Design Strategies Targeting Biopharmaceuticals to the Cytoplasm and Nucleus.

Authors:  Erik V Munsell; Nikki L Ross; Millicent O Sullivan
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.